It has been shown that phenylalanine hydroxylase activity can be altered in inflammation or malignancy [49,50] and some metabolomic studies, using different methodological approaches, corroborate its alteration in CRC [48,51,52,53]. This evidence concerns the gene PAH and colorectal carcinoma.